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Abstract Nuclear proteins of the human peripheral blood T 
lymphocytes that bind to the CREs located within three 21-bp 
repeat enhancers of the HTLV-I promoter belong to the CREBI 
CREM family of bZIP transcription factors. It has been shown 
previously that Tax enhances transactivation of these CREs by 
direct interactions with the bZlP domain of the transcription 
factors to stabilize DNA-binding. We show that CREB and 
CREM bind all three CRE sequences of the HTLV-I promoter 
which are important determinants in Tax-elicited transactivation 
as well as PKA-mediated activation of the HTLV-I promoter. 
Tax and PKA activate transcription from a HTLV-I-LTR CAT 
reporter plasmid transfected to NIH 3T3 cells, and CREM atten- 
uates the activation. In the context of a GAL4 CREB fusion 
protein in which the DNA-binding bZIP domain of CREB is 
replaced by GAL4 binding domain, a single amino acid substitu- 
tion of serine-133, phosphorylated by PKA and critical for the 
transactivation function of CREB, attenuates both Tax and 
PKA-mediated transcriptional responses. These observations 
suggest hat Tax enhances CREB-mediated transactivation of the 
HTLV-I promoter by a mechanism apart from, and/or in addition 
to, the reported stabilization of DNA-binding by interaction with 
the bZIP domain of CREB. 
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1. Introduction 
The lymphotropic and neurotropic pathogenic action of the 
HTLV-I virus is well established in HTLV-I-associated is- 
eases, including adult T cell leukemia [1,2], inflammatory 
arthropathy resembling rheumatoid arthritis [3,4], and the neu- 
rological disorder tropical spastic paraperesis [5]. The chronic 
nature of these diseases indicates a tight transcriptional regula- 
tion of HTLV-1 expression. The HTLV-I promoter contains 
three imperfect repeats of 21 nucleotides with asymmetric 
CREs that govern the response of the promoter to the transac- 
tivator protein Tax and to varying cAMP levels [6--8]. The 
critical role of CREs in Tax-mediated transactivation of the 
HTLV-I promoter has been proven by saturation mutagenesis 
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of the HTLV-I promoter [6,9]. Tax is the viral gene product 
responsible for the autoregulation f the HTLV-I promoter and 
has been shown not to bind directly to target DNA [10,11]. 
Instead, Tax is believed to indirectly interact with CREs of the 
HTLV-I 21-bp repeats by forming protein-protein complexes 
with transcription factors [12,13]. It has been reported that Tax 
stabilizes the binding of CREB and other CRE-binding pro- 
teins to the CREs specifically in the 21-bp repeats of the HTLV- 
I promoter by interactions with the basic region/leucine zipper 
domain involved in DNA-binding [14-16]. Here we report evi- 
dence that Tax stimulates CREB-mediated transcription of the 
HTLV-1 LTR by a mechanism in addition to the stabilization 
of DNA-binding. 
2. Materials and methods 
2.1. PlasmM constructs 
For the preparation of the (3 x GAL4) HTLV-I LTR CAT reporter 
used in these studies, site-directed mutagenesis, using oligonucleotides 
corresponding to the 17mer GAL4 DNA-binding recognition se- 
q uences UASG [I 7], was performed to substitute all three 21-bp repeats 
of the HTLV-I LTR CAT reporter (CR-CAT)[18]. The sequences and 
the orientations of the inserted oligonucleotides were confirmed by 
dideoxy-chain termination sequencing. The GAL4CREB and Ser-133 
to Ala mutant expression vector GAL4CREB muts133A were prepared by 
PCR and site-directed mutagenesis [19,20]. Plasmid constructs encod- 
ing human lull-length CREB [19] and CREM (CREMr~) [21] were 
cloned into bacterial expression vector pRSET (Invitrogen, San Diego, 
CA) using standard procedures [22], and bacterial lysates were prepared 
as described [23]. The eukaryotic expression vectors for Tax and the 
catalytic subunit of PKA were kindly provided by Dr. M. Nerenberg 
[24] and Dr. R. Maurer [25], respectively. 
2,2. Cell lines and transient transfections 
NIH3T3 cells were grown in Dulbecco's modified Eagle's medium 
supplemented with 10% calf bovine serum and antibiotics to approxi- 
mately 25% confluence in 100-mm-diameter culture dishes (Gibco 
BRL, Gaithersburg, MD). The cells were transfected with 2 yg of 
reporter and 1 fig of activator and transactivator DNA expression 
constructs as indicated. Transient transfections were performed using 
the calcium phosphate precipitation method [26]. Harvesting of cells, 
preparation of cell extracts, CAT assays and quantification on the 
Phospholmager (Betascope) were performed as described [27]. 
2.3. Isolation o/peripheral blood T cells" 
Buffy coat leukocyte were obtained from healthy adult blood donors, 
and peripheral blood mononuclear cells were isolated by using Ficoll- 
Hypaque (Pharmacia, Piscataway, N J). Monocytes were depleted by 
adherence toplastic, 2 x 45' in RPMI (Gibco BRL, Gaithersburg, MD) 
at 37°C. Recovered cells were depleted of B cells by using magnetic cell 
sorting IMACS, Miltenyi Biotec, Sunnyvale, CA). Staining with anti- 
CD 19-microbeads and separations on MACS columns were performed 
according to the manufacturer's in tructions, except hat the buffer 
used was RPMI with 1.0% bovine serum albumin. Cell surface staining 
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and flow cytometry was pertormed as described [28].The T cell-enriched 
populations of cells typically contained less than 4% CD20+B cells, less 
than 3% CDI4 + monocytes, and 15 23% CD16 ÷ natural killer cells, as 
revealed by flow cytometry (data not shown). 
2.4. Nuclear extracts and electromobili O' shiJt assays (EMSA) 
Nuclear extracts were prepared by modified method of Dignam [29]. 
Binding reactions were performed in a 20/A reaction volume containing 
20 mM HEPES, 1 mM MgCI,, 50 mM KCI, 12% glycerol, 0.1 mM 
EDTA, 0.5 mM PMSF (phenylmethylsulfonic acid), 0.5 mM DTT 
(dithiothreitol), 1 /~g of nuclear protein and 1 /lg poly{d(A-T)/ 
(Boehringer-Mannheim, Germany) as an unspecific ompetitor. 3:p. 
Labeled oligonucleotide and, where indicated, unlabeled competitor 
oligonucleotides in excess were added and incubated for 30 rain at room 
temperature. Samples were run on a 4% polyacrylamide gel in 
0.5 xTBE at 150 V for 2 h. The dried gels were exposed for autora- 
diography overnight. 
2.5. Oligonucleotides 
Oligonucleotides were annealed and labeled with [~-32p]dATP (New 
England Nuclear, Billerica, MA). Oligonucleotides with 5' overhang 
were labeled with Klenow polymerase (Boehringer-Mannheim, 
Germany). The sequences of the oligonucleotides u ed are shown in 
Table 1. 
2.6. lmmunochemical identification of nuclear jactors (antibody 
EMSA / 
Nuclear extracts, antibodies, and oligonucleotides were incubated at 
room temperature for 30 min. The sera used were rabbit polyclonal 
A CREB TNE 
/ / / / / /  
serum 'P  I "P  I ' ' p~" '~T ' 'p"~r"~ 
R I090 anti-CREB antiserum raised against he P-box peptide consist- 
ing of amino acids 92 124 of CREB [19] and preimmune rabbit serum. 
2. 7. DNA-protein binding and UV-crosslinking 
Short, photoreactive BrdU-substituted 1H21CRE ~ oligonucleotide 
duplexes were prepared as described [30]. For in situ DNA-protein 
crosslinking, polyacrylamide slabs from EMSA were placed on a 300 
nm UV light source (Fotodyne; 7000 mW/cm 2) and irradiated for 20 
rain. DN~prote in  complexes were excised and analyzed by discontin- 
uous SDS/7.5% PAGE under reducing conditions. 
3. Results 
The pal indromic CRE sequence (TGACGTCA)  exemplified 
by COL8 [19] is composed of two functional CGTCA units 
essential for cAMP response [31] which overlap in opposite 
DNA strands, forming a symmetrical CRE (Table 1). In con- 
trast, CREs in the 21-bp repeats of HTLV-I (H21CRE) fall into 
the second category of low affinity sites represented by asym- 
metric CREs (Table I). Asymmetric CREs contain only one 
CGTCA unit in the opposite antisense orientation and an im- 
perfect CGTCA unit in the sense orientation. Although se- 
quences adjacent o CRE elements are important  for the bind- 
ing of proteins, it is generally believed that the presence of at 
least one CGTCA unit, and not the presence of the pal indromic 
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Fig. l. EMSAs with oligonucleotides containing CRE sites in the 21-bp repeats of the HTLV-I promoter. (A) Binding of bacterially expressed 
recombinant CREB and proteins in extracts of nuclei prepared from peripheral blood T cells (TNE) to 32p-labeled oligonucleotides corresponding 
to 21-bp repeats of HTLV-I LTR (lanes 1 12). The EMSA compares the binding of CREB and T cell nuclear proteins to wild type HTLV-I 21-bp 
repeats IH21CRE, 2H21CRE, 31-121CRE (Table 1). The effects of incubating CREB or nuclear extracts with either rabbit preimmune serum (P), 
or immune RI090 CREB antiserum (1) raised against he CREB 'P-box' peptide in the EMSA binding reactions are shown. 'CREB' indicates the 
prevalent complex formed between bacterially expressed CREB protein and DNA. 'SS' indicates complexes that are supershifted with the CREB 
R1090 antiserum, * denotes a non-specific complex detected with various intensity also with the preimmune rabbit serum. Of the four complexes 
(I, II, II1 and IV) detected in the EMSA of peripheral blood T cell nuclear proteins with preimmune rabbit serum (P), incubation with R1090 CREB 
antiserum (I) supershifted complexes I and II to the complexes denoted as Is and IIs and eliminated complex III. (B) Cross-competition f binding 
for EMSA complexes I, II, III and IV in T cell nuclear extracts (TNE) with the IH21CRE 32P-radioactively abeled probe 1H21CRE (lanes 13-17) 
indicate that competition with a 100-fold excess of unlabeled probe I H21CREwt competes all four complexes while the mutated probes 1H21CRE- 
mut, 1H21CREGmut and 1H21CRETTmut compete only complexes Ill and IV. Bacterially expressed recombinant CREM binds effectively to the 
-~2P-labeled oligonucleotides corresponding to the three 21-bp repeats of HTLV-I LTR (lanes 18 20). 
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Fig. 2. In situ UV crosslinking of peripheral blood T cell nuclear proteins to the Br-dUTP-substituted IH21CRE c probe. (A) Preparative EMSA 
gel with resting T cell nuclear extract (TNE) and bacterially expressed recombinant CREM and CREB proteins. EMSA of nuclear extract from human 
peripheral blood T cells (TNE) with the 1 H21CRE c probe is shown in the presence of preimmune rabbit sera (P) or R 1090 antibody (I). Band 1 depicts 
DNA-protein complex bound outside CRE of HTLV-I 21 -bp repeat. Bands 4 and 5 are supershifted bands 2 and 3 of DNA-protein complexes binding 
via CRE of HTLV-I 21-bp repeat. Complexes in bands 2, 3, 4 and 5 observed with BrdU substituted 1H21CRE ~ probe correspond to complexes 
I, II, Is and IIs observed with the HTLV-I 21 bp repeat probes respectively. Bands 6 and 7 depict DNA-protein complexes with full-length CREM 
and full-length CREB. The UV-irradiated wet gel was exposed to autoradiography film for 1 h at 4°C and then the complexes in bands 1 7 were 
excised and fractionated by SDS-PAGE. (B} Autoradiogram of the analytical SDS-PAGE gel showing the proteins detected in EMSA complexes 
1 to 7 shown in panel A. The positions of molecular markers are shown along the left margin. 
Table 1 
Coding strand sequences of CREs in 21-bp repeats of HTLV-I LTR 
oligonucleotides u ed in the DNA-binding studies 









5 -AAGGCTC TGACGTCT 
5 -TAGGCCC TGACGTGT 
5 -CAGGCGT TGACGACA 
5 -AAGGCTC TGACGTCT 
5 -AAGGCTC CAACGTCT 
5 -AAGGCTC TGAGGTCT 
5 -AAGGCTC TGATTTCT 
5 ' -CGGC TGACGTCA 
CCCCCC-3 '  
CCCCCT-3 '  
ACCCCT-3 '  
CCCCCCGGAGGGCAG-3 '  
CCCCCC-3 '  
CCCCCC-3 '  
CCCCCC-3 '  
TCAAGCTA-3 '  
Sense unit CGTCA 
CRE consensus TGACGTCA 
Antisense unit ACTGC 
All of the oligonucleotides have 5' GATC overhangs. The wild type 
HTLV-I 21-bp repeats oligonucleotides 1H2ICRE, 2H21CRE, 
3H21CRE comprise sequences of the HTLV-I LTR from nucleotide 
-251 to -231 (1H21CRE), -203 to -184 (2H2ICRE), and -103 to -82 
(3H21CRE) relative to the transcription start site (+ 1). The mutated 
bases in the distal 21-bp repeat oligonucleotides (1H21CRE-mut. 
1H21CREGmut, 1H21CRETTmut) are underlined. IH21CRE c was 
used for the preparation of Br-dUTP-substituted probe for the in situ 
UV crosslinking. 
sequence itselL confers the binding of CREB homodimers to 
DNA [32]. To directly compare the affinities of CREs in the 
HTLV-I 21-bp repeats, these sequences were incubated with 
bacterially expressed CREB protein in EMSA (Fig. 1A). 
Next, we determined whether bacterially expressed recombi- 
nant CREB can be recognized in EMSA by an antiserum 
(RI090) directed against a peptide from the P-box of CREB. 
In the presence of R1090 we observed a supershift of the more 
intense band, indicating that CREB bound to the CREs of the 
2 l-bp repeats can be specifically recognized by an antiserum to 
a CREB peptide (Fig. 1A, lanes 1-6). Recombinant CREM also 
binds to all three of the HTLV-I CREs (Fig. IB, lanes 18-20). 
To identify T-cell nuclear proteins that bind to the CRE 
elements of the HTLV-I 21-bp repeats, we investigated the 
binding of proteins in nuclear extracts prepared from human 
peripheral blood T cells (Fig. 1A, lanes 7-12). Incubation with 
the 21-bp probes (1H21CRE, 2H21CRE, 3H21CRE) yielded 
tour distinct complexes, denoted I, II, III and IV (Fig. 1A). Two 
complexes (III and IV) could be explained by DNA-prote in  
interactions involving sequences outside of the CRE element as 
they were competed with an excess of oligonucleotides contain- 
ing mutated CRE recognition sequences (1H21CRE-mut, 
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Fig. 3. CREB and CREM modulate Tax and PKA response of HTLV-I kTR. (A) Schematic representation f constructs encoding HTLV-I LTR 
reporters (CR-CAT) where 21-bp repeats are replaced with GAL4 DNA binding sites UASc; (3 x GAL4-CR-CAT) and GAL4-CREB fusion proteins 
GAL4CREB and GAI_4CREB mutant substituted by Ala on Ser-133 (GAL4CREB~UtS~3A). (B) Overexpression of CREM downregulates PKA c and 
Tax response of CR-CAT. The fold stimulations in the presence ofTax of PKA~ are shown as indicated. (C) Mutation of Ser-133 of CREB alone 
can modulate the Tax and PKA response in GAL4CREB-mediated 3 × GAL4-CR-CAT transactivation. CAT activities were normalized relative 
to the basal activity of the 3 × GAE4-CR-CAT reporter in the presence ofGAlA DNA binding domain only. Although the figure represents the 
results of a single xperiment, similar Tax and PKA~ activation was observed in l\~ur independent experiments. 
IH21CREGmut, 1H2ICRETTmut)(Fig. lB. lanes 13-17, and 
Table 1). The remaining two bands (I and lI) contained DNA + 
protein complexes that were not competed by oligonucleotides 
with mutated CRE recognition sequences, indicating that pro- 
tein in complexes I and II are bound via the CRE element. This 
observation suggested that the proteins in complexes I and 11 
bind the 21-bp repeats via the CRE element similar to that of 
CREB. To address this question we determined whether T cell 
nuclear proteins present in complexes l and II could be recog- 
nized by antiserum R1090 that is specific for the recognition of 
CREB and CREM. Indeed, both complexes I and II, but not 
complexes lII and IV+ were supershifted by the antiserum to 
give new complexes I and lls with 21-bp repeats tested. Nota- 
bly, complex IIl was disrupted by antiserum R I090 on all three 
21-bp repeats tested (Fig. IA, lanes 8, 10, and 12). These find- 
ings indicated the presence of CREB and/or CREM isoforms 
bound to the CREs in the complexes I and II (Fig. IB). 
To further elucidate the nature of the proteins in complex I
and II, a specific BrdU-substituted probe for DNA-protein 
crosslinking by UV light was prepared. Incubation with this 
probe (1H21CRE ~) based on the sequence of the distal 21-bp 
repeat of HTLV-I LTR, including the flanking sequences 
(Table 1), yielded several complexes, three of which were fur- 
ther pursued in our analysis (bands 1 to 5, Fig. 2A). Band 1 
depicts a DNA protein complex bound outside of the core 
CRE of 1H21CRE ~ probe. Bands 2 and 3 observed with BrdU 
substituted 1H21CRE ~ probe (Fig. 2) correspond to complexes 
1 and II recognized by the HTLV-1 21 bp repeat probes (Fig. 
l). Similarly bands 4 and 5 (Fig. 2) supershifted in the presence 
of R1090 antiserum correspond to complexes I  and IIs (Fig. 
1 ), suggesting that CREB and/or CREM isoforms are members 
of these complexes. For comparison, bacterially expressed full- 
length CREM and CREB were incubated with the oligonucle- 
otide probe (Fig. 2A, bands 6 and 7). DNA-binding proteins 
were crosslinked to the labeled BrdU-substituted 1H21CRE ~ 
probe using UV light. DNA protein adducts (1-7) (Fig. 2A) 
were excised and the complexes were resolved by SDS-gel elec- 
trophoresis (Fig. 2B, SDS-PAGE). The migration of complexes 
excised from bands 2 and 3 (Fig. 2B, lanes 2 and 3) were similar 
to that of the bacterially expressed recombinant CREM and 
CREB isoforms in lanes 6 and 7, respectively. Furthermore, 
complexes excised l¥om bands 2 and 4, as well as 3 and 5, 
displayed almost identical patterns, supporting the conclusion 
that complexes Is and Ils are supershifted by the antiserum 
R I090, respectively. These data indicate that certain of the 
proteins in nuclear extracts of human resting T cells that bind 
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to the 21-bp repeats of HTLV-I via the CREs are CREB/ 
CREM proteins. Not all of the proteins binding to the 21-bp 
repeats comigrate with CREB/CREM isoforms, because some 
proteins bind outside of the CRE. For example, the complex 
in band 1 (Fig. 2A) migrated in a clearly different range of 
molecular weight (about 100 kDa) (Fig. 2B). 
To elucidate whether the binding of CREB to the CREs is 
functionally significant, we carried out transient transcriptional 
transactivation assays in transfected fibroblast NIH 3T3 cells, 
using a HTLV-I LTR-CAT reporter plasmid (CR-CAT) and 
expression plasmids encoding either Tax or the catalytic sub- 
unit of protein kinase A (PKA~,). Both Tax and PKA~ activated 
the CR-CAT reporter (Fig. 3B). Further, the activation was 
inhibited by cotransfection of an expression plasmid encoding 
the cAMP response lement modulator CREM (Fig. 3B). Be- 
cause the mechanism of action of Tax-mediated stimulation of 
transcription is reported to be a stabilization of the binding of 
CREB and other bZIP proteins to the CRE through specific 
interaction with the bZIP domain [13 16], and because of the 
presence of multiple endogenous CRE-binding proteins, we 
used the 'domain-swap' approach in which the DNA-binding 
domain of CREB is removed and substituted for by the DNA- 
binding domain of the yeast transactivator GAL4, GAL4(I 
147). In addition, this approach obviates undesired interactions 
with the multiple ndogenous CRE-binding proteins, including 
isoforms of CREB and CREM. GAL4 is not known to bind 
to DNA control elements in animal cells [20]. Correspondingly, 
all three 21-bp repeats in the wild type HTLV-I-LTR-CAT 
reporter (CR-CAT) were substituted with three GAL4 DNA 
binding sites (3 x GAL4-CR-CAT) (Fig 3A). In addition, 
recent observations indicate that GAL4 DNA-binding domains 
dimerize in a manner analogous to bZIP domains, although this 
dimerization is not facilitated by Tax [14]. Thus Tax is not 
expected to enhance transcription by stabilizing the binding of 
GAL4CREB fusionproteins. Overexpression of the GAL4(I 
147) DNA-binding domain itself did not activate 3 x GAL4 
CR-CAT activity in the presence of Tax in NIH 3T3 cells (Fig. 
3C). However, overexpression f the GAL4CREB(I-261) fu- 
sion protein (GAL4CREB) and Tax (Fig. 3A) resulted in a 
9.6-fold activation, showing that in the context of the 
3 x GAL4-CR-CAT reporter, the Tax response could be at 
least partially reconstituted with GAL4CREB fusion protein. 
The effect of PKA~ on CREB-mediated activation of HTLV-I 
transcription was approximately 3-fold above the basal level 
(GAL4). 
To determine whether the Tax and the PKA response medi- 
ated by GAL4CREB is dependent upon specific phosphoryla- 
tion of serine-133 phosphorylated by the cAMP-dependent 
protein kinase A, we used a GAL4CREB mutant with serine- 
133 altered to alanine GAL4CREBmut sl~3A. Substitution of 
serine-133 to alanine diminished the Tax response by 3-fold 
(Fig. 3B). In accordance with earlier observations, ubstitution 
of serine-133 by alanine also abrogated the PKA response. 
These results directly implicate serine-133 of CREB in the Tax 
response, even in the absence of the bZIP domain of CREB 
which is lacking in the GAL4CREB. This finding further sug- 
gests that the reported failure of Tax to elevate cellular cAMP 
levels [8] does not necessarily exclude Tax from the utilization 
of the same target molecule (CREB) via signaling pathway(s) 
apart from PKA-mediated phosphorylation of the serine-133 
of CREB. 
4. Discussion 
Our DNA-binding studies performed with nuclear extracts 
prepared from human peripheral blood T lymphocytes confirm 
that proteins of the CREB/CREM family of transcription fac- 
tors bind to the CREs of the HTLV-I promoter. The role of 
CREB in regulation of the activity of the HTLV-I promoter 
was further studied using GAL4CREB fusion proteins and an 
HTLV-I promoter construct in which the 21-bp repeats were 
replaced by GAL4 DNA-binding sites. In this context, both 
Tax and PKA stimulate GAL4CREB-mediated transactivation 
of gene transcription i the absence of the CREB bZIP domain. 
This transactivation was significantly reduced when serine-133 
of CREB was substituted by alanine. Phosphorylation of 
serine-133 by PKA, or other protein kinases, is known to be 
critical for the generation of its transactivational ctivity 
[19,33,34], probably by enhancement of its interactions with the 
CREB-binding protein (CBP), a novel cAMP-responsive pro- 
tein that couples enhancer binding proteins to the basal RNA 
polymerase complex [35-37]. Our observations indicate that 
Tax stimulates CREB-mediated transactivation f the CREs in 
the HTLV-I 21-bp repeats by a mechanism in addition to the 
stabilization of bZIP-specific binding to the DNA, and suggest 
that the mechanism ay be to enhance interactions of CREB 
with CBP. Our data are consistent with the idea that 
phosphorylated CREB is a target for CBP, and that Tax may 
also enhance the recruitment and/or stabilization of the binding 
of phosphoCREB to CBP. Our findings are also consistent with 
the reported observations that sequences located amino-proxi- 
mal to the binding domain of CREB are required for the Tax- 
mediated stimulation of DNA-binding [38] and that Tax di- 
rectly binds to CBP [39]. 
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